Robert W. Duggan - 29 Apr 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Robert W. Duggan
Issuer symbol
SMMT
Transactions as of
29 Apr 2025
Net transactions value
$0
Form type
4
Filing time
01 May 2025, 18:09:55 UTC
Previous filing
09 Apr 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +1,040,000 1,040,000 29 Apr 2025 Common Stock 1,040,000 $1.06 By Spouse F1, F2, F3
transaction SMMT Stock Option (right to buy) Award +400,000 400,000 29 Apr 2025 Common Stock 400,000 $1.29 By Spouse F1, F2, F3
transaction SMMT Stock Option (right to buy) Award +9,590,558 9,590,558 29 Apr 2025 Common Stock 9,590,558 $1.68 By Spouse F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025.
F2 Not applicable.
F3 The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.